Composite Resources, Inc. v. Parsons

District Court, E.D. California·Decided September 12, 2022·No. 2:21-cv-02352·Unknown

Opinion

Composite Resources, Inc., No. 2:21-cv-02352-KJM-DMC Plaintiff, ORDER v. Derek R. Parsons, 1S Defendant. Defendant Derek Parsons, the chief operating officer of Recon Medical, LLC, moves to dismiss plaintiff Composite Resources, Inc.’s six claims of patent infringement on claim preclusion grounds. As explained below, Composite’s lawsuit in this court concerns the same patents, the same infringing products, and mostly the same claims at issue in its now-concluded lawsuit against Recon in the District of Nevada. Because Composite’s lawsuit concerns claims that were or could have been raised in its Nevada lawsuit, and because no exception to claim preclusion applies, the court grants Parsons’ motion to dismiss. I. BACKGROUND Composite owns three related patents: Nos. 7,842,067 (the ’067 patent), 7,892,253 (the °253 patent), and 8,888,807 (the ’807 patent). See Compl. 9 8-10, ECF No. 1. All three concern anovel tourniquet, a medical device for restricting blood flow. See, e.g., °067 Patent, Compl. Ex. A, ECF No. 1-1.

In January 2017, Composite sued Recon in the District of Nevada, alleging Recon’s Gen 1, Gen 2, Gen 3 and Gen 4 tourniquets infringed its patents. See Compl. ¶¶ 13–18, 22–25. Composite brought claims for unfair competition, trademark infringement and patent infringement. See id. ¶ 18. The District of Nevada court found Recon liable for unfair competition and trademark infringement as a matter of law in July 2019. Id. ¶¶ 19–20. On September 3, 2021, the same day that court set a trial date for Composite’s remaining patent infringement claim, Recon filed for Chapter 11 Bankruptcy. Id. ¶¶ 26–27. Composite then dropped its request for damages and moved forward with its lawsuit seeking only injunctive relief. See id. ¶¶ 28, 30. The trial ultimately went forward on November 30, 2021. Id. at 33. After both sides rested their cases, the court found as a matter of law that the ’067 patent, the ’253 patent and the ’807 patent were valid, id. ¶ 34, and the jury then found all of Recon’s tourniquets infringed Composite’s patents, id. ¶ 35. At a subsequent hearing, Composite requested Recon cease “committing acts of infringement pending a determination by the court whether to grant equitable relief in the form of an injunction.” Id. ¶ 36. Recon “refused” to agree, leaving the dispute for the court to resolve. Id. The Nevada court issued its injunction order roughly a month later, on January 6, 2022. See generally Perm. Inj. Order,1 ECF No. 16-1. The court permanently enjoined Recon, and anyone affiliated with Recon, from using, selling, importing, or monetizing in any way its infringing tourniquets. See id. at 13. The court explained Composite’s decision not to pursue monetary damages against Recon: [Composite’s] decision not to seek monetary damages was forced by Recon’s decision to file bankruptcy. [Composite] basically faced a Hobson’s choice: either abandon this case altogether after years of litigation or get an order from the bankruptcy court that would only 1 The court takes judicial notice of the Nevada court’s January 6, 2022 permanent injunction order. See Intri–Plex Tech., Inc. v. Crest Grp., Inc., 499 F.3d 1048, 1052 (9th Cir. 2007) (“A court may take judicial notice of matters of public record . . . as long as the facts noticed are not subject to reasonable dispute.” (internal citation & quotation marks omitted)); Reyn’s Pasta Bella, LLC v. Visa USA, Inc., 442 F.3d 741, 746 n.6 (9th Cir. 2006) (“We may take judicial notice of court filings and other matters of public record.”). allow it to pursue injunctive relief in this Court because there was no question it could no longer seek monetary damages in this case. Id. at 10. On December 17, 2022—fifteen days after Recon “refused” to stop selling its infringing tourniquets, but twenty days before the Nevada court issued its permanent injunction—Composite filed this lawsuit against defendant Parsons, Recon’s chief executive officer. See generally Compl. Composite alleges Parsons “controls Recon” and has “ultimate authority” over all of Recon’s business activities. Id. ¶ 2. Specifically, Composite describes Parsons as the “moving force” and the person “responsible for all of [Recon’s] relevant decisions” that led to the “tortious acts of patent infringement” at issue in the Nevada lawsuit. Id. Composite further alleges Parsons directed Recon’s litigation decisions in the Nevada lawsuit and insisted Recon sell its infringing tourniquets pending the Nevada court’s injunction ruling. Id. ¶¶ 33, 36. Composite’s six claims against Parsons are as follows: (1) through (4), infringement of its ’067, ’253 and ’807 patents, id. ¶¶ 45–92; (5) inducement of infringement of those patents, id. ¶¶ 93–102; and (6) civil conspiracy to commit unlawful acts of patent infringement, id. ¶¶ 103–126. Parsons moves to dismiss under Federal Rule of Civil Procedure 12(b)(6), arguing claim preclusion bars Composite’s lawsuit in this court.2 See generally Mot., ECF No. 13-1. The court received full briefing and heard oral arguments at a hearing on May 27, 2022. See Opp’n, ECF ///// 2 Parsons’ motion rests exclusively on claim preclusion, also known as “res judicata.” Res judicata is an affirmative defense and is typically pled as such. See Fed. R. Civ. P. 8(c)(1) (“In responding to a pleading, a party must affirmatively state any avoidance or affirmative defense, including: . . . res judicata.”). The court will nevertheless rule on Parsons’ motion to dismiss. The court has the facts necessary to rule on the motion, and there appears to be no other reason why an answer would be useful. See Scott v. Kuhlmann, 746 F.2d 1377, 1378 (9th Cir. 1984) (per curiam) (affirming district court’s dismissal of plaintiff’s complaint where “[t]he defendants raised res judicata in their motion to dismiss under Rule 12(b)(6)” because although “[o]rdinarily affirmative defenses may not be raised by motion to dismiss, . . . this is not true when, as here, the defense raises no disputed issues of fact”); Magana v. Commonwealth of the Northern Mariana Islands, 107 F.3d 1436, 1446 (9th Cir. 1997) (noting Ninth Circuit has “liberalized the requirement that defendants must raise affirmative defenses in their initial pleadings.”); accord Hartmann v. Time, Inc., 166 F.2d 127, 138 (3d Cir. 1947) (noting that claim preclusion “ordinarily is pleaded as an affirmative defense under Rule 8(c) of the Federal Rules of Civil Procedure[,] but this is a mere matter of form”). No. 16; Reply, ECF No. 20; Mins., ECF No. 25. William Klett and William O’Hare appeared for plaintiff Composite; Perry Clark appeared for defendant Parsons. Mins., ECF No. 25. Composite offers three reasons why claim preclusion does not bar its lawsuit in this court. The court assesses these reasons in the order best allowing for organizational clarity. First, although Composite acknowledged at hearing it could have brought the subject claims against Parsons in its Nevada lawsuit, it argues claim preclusion does not apply because Parsons was not a party to the Nevada lawsuit. See Opp’n at 8–12. Second, Composite argues the continued offering and selling of Recon’s patent-infringing tourniquets after Composite filed its Nevada lawsuit “fit[s] into a ‘temporal exception’ to [claim preclusion].” See id. at 6–7. Third, Composite p

Free access — add to your briefcase to read the full text and ask questions with AI

Composite Resources, Inc. v. Parsons, (E.D. Cal. 2022).

Composite Resources, Inc. v. Parsons (Composite Resources, Inc. v. Parsons) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Gillig v. Nike, Inc.
602 F.3d 1354 (Federal Circuit, 2010)
Roche Palo Alto LLC v. Apotex, Inc.
531 F.3d 1372 (Federal Circuit, 2008)
United States v. Itt Rayonier, Incorporated
627 F.2d 996 (Ninth Circuit, 1980)
W. Eugene Scott v. Edward L. Kuhlmann, Etc.
746 F.2d 1377 (Ninth Circuit, 1984)
Burgos v. Hopkins
14 F.3d 787 (Second Circuit, 1994)
Kolela Mpoyo v. Litton Electro-Optical Systems
430 F.3d 985 (Ninth Circuit, 2005)
Intri-Plex Technologies, Inc. v. Crest Group, Inc.
499 F.3d 1048 (Ninth Circuit, 2007)
Hartmann v. Time, Inc.
166 F.2d 127 (Third Circuit, 1948)
Brain Life, LLC v. Elekta Inc.
746 F.3d 1045 (Federal Circuit, 2014)
Senju Pharmaceutical Co. v. Apotex Inc.
746 F.3d 1344 (Federal Circuit, 2014)
Knight v. Alabama
14 F.3d 1534 (Eleventh Circuit, 1994)
Clark v. Bear Stearns & Co.
966 F.2d 1318 (Ninth Circuit, 1992)